Literature DB >> 28625602

FRAX Score Can Be Used to Avoid Superfluous DXA Scans in Detecting Osteoporosis in Celiac Disease: Accuracy of the FRAX Score in Celiac Patients.

Raffaella Tortora1, Nicola Imperatore2, Pietro Capone2, Nicolò Gerbino2, Matilde Rea2, Giovanna Affinito3, Nicola Caporaso2, Antonio Rispo2.   

Abstract

The Fracture Risk Assessment (FRAX) tool has been developed to estimate patients' 10-yr probability of fracture, thus establishing which patients should undergo dual-energy X-ray Absorptiometry (DXA) scan. This study aimed to evaluate if the FRAX tool can replace or optimize the use of DXA scan in celiac disease (CD). We prospectively enrolled all CD patients aged over 40 yr diagnosed at our third-level unit. At time of CD diagnosis, all patients underwent FRAX score calculation for risk of major osteoporotic and hip fractures and DXA scan (used as gold standard) to assess the accuracy of the FRAX score. The FRAX score calculation was based on the following 10 variables: age (>40 yr), sex (M/F), body mass index, history of previous fracture (yes/no), parent fractured hip (yes/no), current smoking (yes/no), use of steroids (yes/no), rheumatoid arthritis (yes/no), secondary osteoporosis (yes/no), and alcohol ≥3 units/d (yes/no). DXA assessment was performed within 1 week from FRAX calculation. The FRAX score was dichotomized as normal or pathologic in accordance with the National Osteoporosis Guideline Group. A total of 160 CD patients were enrolled (M/F = 20/140; mean age 48.7 yr). A pathologic FRAX score was evident in 14 out of 160 patients (8.7%), whereas osteoporosis based on DXA scan was found in 10 patients (6%) (κ = 0.6); 3 patients with osteoporosis (1.9%) showed a 10-yr risk of major fracture >10% according to the National Osteoporosis Guideline Group criteria. With regard to diagnostic accuracy, the FRAX score showed sensitivity of 0%, specificity of 91%, positive predictive value of 0%, and negative predictive value of 94%. The prevalence of osteoporosis in adult CD appears to be quite low and only a small proportion of patients would require a DXA investigation. The FRAX score could be an effective tool to avoid useless DXA scans in CD patients in view of its high negative predictive value.
Copyright © 2017 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone mineral density; DXA scan; FRAX score; celiac disease; osteoporosis

Mesh:

Year:  2017        PMID: 28625602     DOI: 10.1016/j.jocd.2017.05.010

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  5 in total

Review 1.  Bone Fragility in Gastrointestinal Disorders.

Authors:  Daniela Merlotti; Christian Mingiano; Roberto Valenti; Guido Cavati; Marco Calabrese; Filippo Pirrotta; Simone Bianciardi; Alberto Palazzuoli; Luigi Gennari
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

2.  Investigation of the Factors Affecting Bone Mineral Density in Children with Celiac Disease.

Authors:  Seyed Mohsen Dehghani; Homa Ilkhanipour; Leila Samipour; Ramin Niknam; Iraj Shahramian; Fateme Parooie; Morteza Salarzaei; Masoud Tahani
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-03-10

3.  Risk modeling of femoral neck fracture based on geometric parameters of the proximal epiphysis.

Authors:  Anna D Shitova; Olga N Kovaleva; Anna V Olsufieva; Inchekhanum A Gadzhimuradova; Dmitry D Zubkov; Mikhail O Kniazev; Tatyana S Zharikova; Yury O Zharikov
Journal:  World J Orthop       Date:  2022-08-18

Review 4.  Review article: Follow-up of coeliac disease.

Authors:  J A Tye-Din
Journal:  Aliment Pharmacol Ther       Date:  2022-07       Impact factor: 9.524

5.  Fracture risk assessment in celiac disease: a registry-based cohort study.

Authors:  D R Duerksen; L M Lix; H Johansson; E V McCloskey; N C Harvey; J A Kanis; W D Leslie
Journal:  Osteoporos Int       Date:  2020-08-03       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.